Determination and validation of aortic calcification measurement from lateral bone densitometry in dialysis patients

Nigel D Toussaint1, Kenneth K Lau, Boyd J Strauss

  • 1Department of Nephrology, Monash Medical Centre, Clayton, Victoria, Australia. Nigel.Toussaint@med.monash.edu.au

Insights

Dual-energy X-ray absorptiometry (DXA) can assess vascular calcification (VC) and bone mineral density (BMD) in dialysis patients. Lateral DXA shows promise for concurrent assessment of aortic calcification and lumbar spine BMD.

Area of Science:

  • Nephrology
  • Cardiology
  • Radiology
  • Bone Metabolism

Background:

  • Vascular calcification (VC) is prevalent in dialysis patients, increasing cardiovascular disease risk.
  • VC is inversely correlated with bone mineral density (BMD).
  • Screening for VC may identify high-risk patients.

Purpose of the Study:

  • To evaluate dual-energy X-ray absorptiometry (DXA) for measuring vascular calcification (VC).
  • To correlate DXA measurements of VC with computed tomography (CT) as the gold standard.
  • To assess DXA's utility in evaluating bone mineral density (BMD) alongside VC.

Main Methods:

  • Abdominal aortic CT and lateral DXA of the lumbar spine were performed on 40 hemodialysis patients.
  • Aortic VC was semiquantitatively measured using 24- and 8-point scales on lateral DXA.
  • DXA-reported BMD was compared with CT-derived BMD.

Main Results:

  • Aortic VC was detected in 94% of patients by CT and 68% by lateral DXA.
  • DXA-measured VC showed significant correlation with CT findings.
  • Lateral DXA-reported BMD correlated significantly with CT BMD, unlike AP DXA.

Conclusions:

  • Lateral DXA may offer a dual role in assessing aortic calcification and lumbar spine BMD concurrently.
  • This method could overcome limitations associated with standard AP DXA for BMD assessment.
  • Lateral DXA shows potential for improved risk stratification in dialysis patients.
Abstract